Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
Fibrin(ogen) degradation products (FDP) are assayed adequately in defibrinated citrated plasma provided that fibrin(ogeno)lysis is prevented during coagulation. The practical consequence is that all screening tests for haemostatic function may be carried out in specimens obtained from citrated blood.
D001780:Blood Coagulation Tests / Q000379:methods*; D002951:Citrates; D005337:Fibrin / Q000378:metabolism*; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D006863:Hydrogen-Ion Concentration
D002951:Citrates; D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D005340:Fibrinogen